Search Results - "Vessey, L.K."

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA α2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers by de Haas, S.L., de Visser, S.J., van der Post, J.P., Schoemaker, R.C., van Dyck, K., Murphy, M.G., de Smet, M., Vessey, L.K., Ramakrishnan, R., Xue, L., Cohen, A.F., van Gerven, J.M.A.

“…The use of non-selective γ-aminobutyric acid (GABA) enhancers, such as benzodiazepines in the treatment of anxiety disorders is still widespread but hampered…”
Get full text

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA A α 2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers by de Haas, S.L., de Visser, S.J., van der Post, J.P., Schoemaker, R.C., van Dyck, K., Murphy, M.G., de Smet, M., Vessey, L.K., Ramakrishnan, R., Xue, L., Cohen, A.F., van Gerven, J.M.A.

“…The use of non-selective γ-aminobutyric acid (GABA) enhancers, such as benzodiazepines in the treatment of anxiety disorders is still widespread but hampered…”
Get full text

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA a2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers by de Haas, S.L, de Visser, S.J, van der Post, J.P, Schoemaker, R.C, van Dyck, K, Murphy, M.G, de Smet, M, Vessey, L.K, Ramakrishnan, R, Xue, L, Cohen, A.F, van Gerven, J.M.A

Get full text